OrbiMed Genesis GP LLC Insider Trading -- Recent SEC Form 4 Transactions

Name: OrbiMed Genesis GP LLC Insider Trading -- SEC Form 4 Transactions
Creator: ko.io

OrbiMed Genesis GP LLC (CIK 1808744) reported 41 SEC Form 4 insider transactions across 10 companies over the past 18 months (most recent 2026-09-30). Recent activity: Buy ADRX (10.7M shares), Buy ADRX (2.0M shares), Buy ADRX (769,601 shares), Buy ADRX (564,187 shares), Buy ADRX (300,249 shares). Source: SEC Form 4.

Date	Company	Role	Type	Shares	Value
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	10.7M	$0
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	2.0M	$0
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	769,601	$0
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	564,187	$0
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	300,249	$5.1M
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	7.1M	$0
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	1.3M	$0
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	513,067	$0
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	256,448	$0
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	61,516	$1.0M
2026-09-30	ADARx Pharmaceuticals, Inc. (ADRX)	Director	Buy	588,235	$10.0M
2026-09-23	Electra Therapeutics, Inc. (ETRA)	Director	Buy	1.1M	$0
2026-09-23	Electra Therapeutics, Inc. (ETRA)	Director	Buy	2.0M	$0
2026-09-23	Electra Therapeutics, Inc. (ETRA)	Director	Buy	1.7M	$0
2026-09-23	Electra Therapeutics, Inc. (ETRA)	Director	Buy	333,333	$5.0M
2026-09-23	Electra Therapeutics, Inc. (ETRA)	Director	Buy	758,279	$0
2026-09-23	Electra Therapeutics, Inc. (ETRA)	Director	Buy	1.0M	$15.0M
2026-08-11	Braveheart Bio, Inc. (BRVE)	Director	Buy	9.1M	$0
2026-08-11	Braveheart Bio, Inc. (BRVE)	Director	Buy	1.7M	$30.0M
2026-08-11	Braveheart Bio, Inc. (BRVE)	Director	Buy	273,333	$4.9M
2026-06-24	Enliven Therapeutics, Inc. (ELVN)	10% Owner	Sell	24,846	$1.1M
2026-06-24	Enliven Therapeutics, Inc. (ELVN)	10% Owner	Sell	1,477	$66,465
2026-06-24	Enliven Therapeutics, Inc. (ELVN)	10% Owner	Sell	787,024	$35.7M
2026-06-24	Enliven Therapeutics, Inc. (ELVN)	10% Owner	Sell	46,776	$2.1M
2026-06-17	Enliven Therapeutics, Inc. (ELVN)	10% Owner	Sell	9,086	$409,052

Source: SEC Form 4 filings · as of 2026-09-30